Molecular Diagnostics Market Essential for Spotting Premature DiseasesPosted by industryarc on August 7th, 2019 Global Molecular Diagnostics Market: Demand Analysis and Growth Forecast The gathered information resonates with the business analysis report from IndustryARC that concluded the Global Molecular Diagnostics Market size to be around .54 billion to .44 billion as of 2018. The market is growing at a positive CAGR of around 4.5% to 4.8% through the forecast period of 2019 to 2025. The molecular diagnostic market is growing because of the fact that diagnostic errors exist and are responsible for a significant number of deaths. Molecular diagnostics is a pool of techniques used to analyze biological markers in the individual’s genetic code and determine the reaction of proteins by applying molecular biology to medical testing. These tests are accessed on a range of medical issues such as pharmacogenomics, human leucocyte antigen typing, oncology, and coagulation. View Full Table Of Content Of Molecular Diagnostics Market: https://www.industryarc.com/Report/10604/molecular-diagnostics-market.html Global Molecular Diagnostics Market: Leading Segments The maximum demands for the molecular diagnostics market are emerging in the North America. The region produced around 34% to 37% of the total demand share in the molecular diagnostics marketplace in 2018. The large market share is justified since the region encapsulates prominent portion of increased chronic, cardiovascular, cancer, and infectious disease as well as robust healthcare infrastructure. Infectious disease is the dominant application segment of the global molecular diagnostics market, with an impressive CAGR of 12% to 15% during the aforementioned forecast period. According to the Centers for Disease Control (CDC), around 1.7 million infections are recorded annually which approximately leads to 99,000 deaths each year. So, an advanced molecular diagnostic system is presumed to optimize the monitoring conditions and reduce infections on a global level. Global Molecular Diagnostics Market Trends The recent decade marked the advancements in the instrumentations and chemistry including integration, automation, ability, and its output to use the instrumentation in a random-access mode. Regular investments and funding in the R&D department of the diagnostic sector of the healthcare industry will lead to significant profits in the global molecular diagnostics market. Global Molecular Diagnostics Market: Competitive Landscape Some of the key companies identified in the report that are currently holding majority shares in the global molecular diagnostics market are: Roche, Hologic, QIAGEN, Abbott Laboratories, and Danaher Corporation. Talk to one of our sales representative about the full report by providing your details in the link below: https://www.industryarc.com/support.php?id=10604 About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare. Contact Us: Like it? Share it!More by this author |